(NP (NP Tumor/NN necrosis/NN factor-alpha/NN mRNA/NN accumulation/NN) (PP in/IN (NP human/JJ myelomonocytic/JJ cell/NN lines/NNS)) ./.)
(NP-COOD (NP (NP Role/NN) (PP of/IN (NP (NP transcriptional/JJ regulation/NN) (PP by/IN (NP DNA/NN sequence/NN motifs/NNS))))) and/CC (NP mRNA/NN stabilization/NN) ./.)
(S (NP-SBJ The/DT cytokine/NN TNF/NN) (VP mediates/VBZ (NP (NP many/JJ) (PP of/IN (NP (NP the/DT pathologic/JJ signs/NNS) (PP of/IN (NP-COOD (NP cachexia/NN) ,/, (NP inflammation/NN) ,/, and/CC (NP sepsis/NN))))))) ./.)
(S (NP-SBJ The/DT current/JJ work/NN) (VP describes/VBZ (NP (NP the/DT regulation/NN) (PP of/IN (NP TNF/NN)) (PP in/IN (NP human/JJ myelomonocytic/JJ cell/NN lines/NNS)) (PP-TMP after/IN (NP PMA/NN stimulation/NN)))) ./.)
(S (NP-SBJ The/DT cell/NN lines/NNS) (VP exhibit/VBP (NP (NP a/DT low/JJ level/NN) (PP of/IN (NP constitutive/JJ TNF/NN mRNA/NN expression/NN)))) ./.)
(S (PP-TMP Within/IN (NP (NP (QP 2/CD to/TO 4/CD) h/NN) (PP of/IN (NP PMA/NN exposure/NN)))) ,/, (NP-SBJ-27 (NP steady/JJ state/NN levels/NNS) (PP of/IN (NP TNF/NN mRNA/NN))) (VP are/VBP (ADVP markedly/RB) (VP elevated/JJ (NP *-27/-NONE-) (PP in/IN (NP (NP all/DT myelomonocytic/JJ cell/NN lines/NNS) (VP studied/VBN (NP */-NONE-)))))) ./.)
(S (NP-SBJ This/DT rise/NN) (VP is/VBZ (PP-PRD due/JJ (PP-COOD (PP to/TO (NP (NP increased/VBN mRNA/NN stability/NN) ,/, (SBAR (WHNP-28 which/WDT) (S (NP-SBJ *T*-28/-NONE-) (VP increased/VBD (PP by/IN (NP almost/RB twofold/RB))))))) ,/, and/CC (PP to/TO (NP (NP an/DT overall/JJ increase/NN) (PP in/IN (NP transcription/NN)) ,/, (SBAR (WHNP-29 which/WDT) (S (NP-SBJ *T*-29/-NONE-) (VP rises/VBZ (PP by/IN (NP more/JJR than/IN sixfold/RB)))))))))) ./.)
(S (PP At/IN (NP (NP the/DT level/NN) (PP of/IN (NP the/DT genomic/JJ TNF/NN gene/NN)))) ,/, (NP-SBJ-30 a/DT DNase/NN I/CD hypersensitive/JJ site/NN) (VP is/VBZ (VP detected/VBN (NP *-30/-NONE-) (PP within/IN (NP (NP the/DT TNF/NN promoter/NN) (PP between/IN (NP (QP -200/CD to/TO -100/CD) bp/NN)))) (PP relative/JJ to/TO (NP the/DT transcription/NN initiation/NN site/NN)))) ./.)
(S (SBAR-ADV Although/IN (S (NP-SBJ *-31/-NONE-) (ADJP-PRD absent/JJ (PP in/IN (NP nonexpressing/VBG erythroleukemia/NN cell/NN lines/NNS))))) ,/, (NP-SBJ-31 the/DT DNase/NN I/CD site/NN) (VP-COOD (VP is/VBZ (ADJP-PRD present/JJ (PP in/IN (NP uninduced/JJ myelomonocytic/JJ cell/NN lines/NNS)))) and/CC (VP is/VBZ not/RB (VP changed/VBN (NP *-31/-NONE-) (PP-TMP after/IN (NP PMA/NN induction/NN))))) ./.)
(S (S (NP (NP The/DT PMA/NN induction/NN) (PP of/IN (NP c-fos/NN mRNA/NN))) (VP correlated/VBD (ADVP well/RB) (PP with/IN (NP TNF/NN gene/NN induction/NN))) ;/:) (S (NP-SBJ-32 (NP expression/NN) (PP of/IN (NP (NP genes/NNS) (VP encoding/VBG (NP (NP other/JJ proteins/NNS) (PP in/IN (NP (NP the/DT AP-1/NN complex/NN) (PRN -LRB-/-LRB- (NP-COOD (NP junB/NN) and/CC (NP junD/NN)) -RRB-/-RRB-)))))))) (VP were/VBD (ADVP also/RB) (VP induced/VBN (NP *-32/-NONE-) (PP by/IN (NP-LGS PMA/NN)))) ./.))
(S (NP-SBJ (NP The/DT nuclear/JJ extracts/NNS) (PP from/IN (NP (ADJP-COOD (ADJP resting/VBG) and/CC (ADJP induced/VBN)) ML-1/NN cells/NNS))) (VP contain/VBP (NP (NP proteins/NNS) (VP binding/VBG (ADVP specifically/RB) (PP to/TO (NP (NP the/DT (NP-COOD (NP AP-1/NN) ,/, (NP AP-2/NN) ,/, and/CC (NP NF/NN kappa/NN B/NN sequence/NN))) (ADJP located/JJ (PP within/IN (NP the/DT TNF/NN promoter/NN)))))))) ./.)
(S (NP-SBJ PMA/NN induction/NN) (VP increases/VBZ (NP (NP the/DT level/NN) (PP of/IN (NP (NP a/DT number/NN) (PP of/IN (NP specific/JJ binding/VBG complexes/NNS))))) (PP relative/JJ to/TO (NP the/DT resting/VBG cells/NNS))) ./.)
(S (NP-SBJ-34 (NP The/DT regulatory/JJ mechanisms/NNS) (PP of/IN (NP the/DT (ADJP-COOD (ADJP human/JJ) and/CC (ADJP murine/JJ)) TNF/NN genes/NNS))) (VP are/VBP (VP discussed/VBN (NP *-34/-NONE-))) ./.)
